We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Assets Trust Regulatory News (PNL)

Share Price Information for Personal Assets Trust (PNL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 485.00
Bid: 484.00
Ask: 484.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.103%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 485.00
PNL Live PriceLast checked at -
Personal Assets is an Investment Trust

To protect and increase shareholders' funds over the long-term by investing in equities, fixed income securities, cash and cash equivalents (which may include gold).

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

24 Nov 2021 07:00

RNS Number : 3268T
Personal Assets Trust PLC
24 November 2021
 

To: RNS

From: Personal Assets Trust plc

LEI: 213800Z7ABM7RLQ41516

Date: 24 November 2021

 

 

Interim Report for the Six months ended 31 October 2021 (Unaudited)

 

Financial Summary

 

Personal Assets Trust ("PAT") is an investment trust run expressly for private investors.

 

The Company's investment policy is to protect and increase (in that order) the value of shareholders' funds per share over the long term.

 

Over the six months to 31 October 2021 PAT's net asset value per share ("NAV") rose by 5.3% to £489.77. PAT's share price rose by £22.00 to £493.00 over the same period, being a premium of 0.7% to the Company's NAV at that date.

 

During the period, PAT continued to maintain a high level of liquidity.

 

% as at

31 October

2021

% as at

30 April

2021

 

 

US TIPS

30.3

32.6

 

UK T-Bills

17.2

8.1

 

Gold Bullion

7.9

8.9

 

Property

0.1

0.1

 

UK cash

3.8

4.7

 

Overseas cash

0.0

0.0

 

Net current liabilities

(0.0)

(0.1)

 

 

Total

59.3

54.3

 

Over the six months PAT's shares continued to trade close to NAV. We issued 221,150 new Ordinary shares (adding £107.1 million of capital) at a small premium.

 

Dividends are paid in July, October, January and April of each year. The first interim dividend of £1.40 per Ordinary share was paid to shareholders on 16 July 2021 and the second interim dividend of £1.40 was paid on 8 October 2021. A third interim dividend of £1.40 per Ordinary share will be paid to shareholders on 12 January 2022 and a fourth interim dividend of £1.40 per Ordinary share is expected to be paid in April 2022, making a total for the year of £5.60 per Ordinary share.

 

 

 

Key Features

 

As at

31 October

2021

As at

30 April

2021

Market Capitalisation

£1,702.9m

£1,522.7m

Shareholders' Funds

£1,691.7m

£1,503.9m

Shares Outstanding

3,454,079

3,232,929

Liquidity (see fourth bullet point above)

59.3%

54.3%

Share Price

£493.00

£471.00

NAV per Share

£489.77

£465.19

FTSE All-Share Index

4,129.16

3,983.85

Premium to NAV

0.7%

1.2%

Earnings per Share

£4.34

£4.53⁽¹⁾

Dividend per Share

£2.80

£5.60⁽¹⁾

⁽¹⁾ Full Year.

 

 

 

Investment Manager's Report

 

Over the half year to 31 October 2021, the net asset value per share ("NAV") of Personal Assets Trust rose by 5.3% while the FTSE All-Share Index ("FTSE") rose by 3.6%. With dividends reinvested, the total returns were 5.9% and 5.4% respectively. Over a three year period the Trust's NAV rose by 23.8% while the FTSE rose by 5.8%. The total returns over the same period were 28.8% and 17.6% respectively.

 

Looking at the Trust's total return over the six months, one might think that we were tracking the index, but such a suggestion could not be further from the truth. This outcome is one of those strange quirks of fate. During the period we held circa 40% of the Trust in equities, and only 7% was invested in the UK stock market. More often than not, our performance will differ materially from the comparator index, and despite this short term coincidence of returns we have continued in our aim to protect and increase (in that order) the value of shareholders' capital. We believe that, in our conservative asset allocation combined with qualitative equity selection, we are taking considerably less risk than that of an index tracker.

 

Investors have been attempting to look through the effects of the pandemic and consider how the economy will recover. Thus far it has been an interrupted journey and we continue to believe that parts of the economy will not fully recover until the middle of this decade. Two areas that continue to show particular resilience, however, are the shifts to the cloud computing and electronic payments. Our equity holdings performed well in the period. Microsoft and Alphabet, the Trust's two largest holdings, generated strong returns supported by robust earnings growth. American Express, Nestlé and Agilent also performed well. The only minor laggard was Visa, held back by the slow reopening of international travel, but we expect this to recover over the next two years.

 

Portfolio activity was modest during the half year. We reduced the Trust's equity exposure as a percentage of the NAV from 45.7% to 40.7%, as markets became more expensive. We sold the Trust's investment in Berkshire Hathaway, which we had held since the aftermath of the financial crisis. Over this time it has contributed strongly to performance. After a more challenging year in 2020, the shares have performed strongly year-to-date, convincingly making new all-time highs. In terms of valuation, the shares have also re-rated and trade towards the upper end of their long-term range. From here there are several risks which we do not believe are adequately discounted; the most prominent is key-man risk which is well known but rises as each year passes - Warren Buffett just celebrated his 91st birthday. Coupled with this has been disappointing recent capital allocation by Berkshire, evident particularly in the decision to purchase airlines, something Buffett has long-warned against, followed by their untimely sale. Finally, the company's refusal to hold its subsidiary businesses to a higher level of account when it comes to climate disclosures is reflective of a management team that is yet to fully grasp the ESG nettle. This is likely to impact returns in the years to come.

 

The other material transaction was the sale of Philip Morris International ("PMI"). Our views on the Trust's tobacco holdings have evolved over the past few years, reflected also in the sale of Altria in 2018 and BAT in early 2021. The purchase by Altria of a 35% stake in JUUL's vaping business for $12bn was the catalyst for this reappraisal. If JUUL could be valued so highly after just five years in existence, and be seen as a threat to Altria's core business, then clearly there was concern over the combustibles' business model. The recent acquisition by PMI of the Ventura inhalers business also does little to instil confidence. Like integrated oil companies and newspapers before them, the tobacco business model is changing, making the future returns less predictable and likely to fall as managements attempt to transform their companies for a post-tobacco world. There is an increasing risk that these companies become wasting assets as they strive for relevance. Moreover, we question the sustainability of paying such high dividends, especially when the sector's indebtedness remains stubbornly high, making less capital available for buybacks than in the past. Rupert Murdoch once described classified advertising revenue as "rivers of gold". A few years later, having witnessed a cascade of classified advertising revenue shift from newspapers to the internet, he admitted: "Sometimes rivers dry up."

 

Central banks want us to believe that the current inflationary pressures are 'transitory'. Whether this is wishful thinking remains to be seen. The base effects of depressed oil prices in April 2020 on inflation figures have long gone and have been followed by supply shocks, as availability of products has been insufficient to meet recovering demand post pandemic. Admittedly, the leaden weight of high government debt levels will weigh for years to come and interest rates are unlikely to rise quickly despite calls to curb inflationary forces. In contrast, the consumer has not been in a stronger financial position for two decades; pent-up demand is translating into spending as pandemic restrictions are removed. As economies re-open, that demand may well strengthen, which may lead to a further phase of inflation taking investors by surprise in 2022/23.

 

Wage growth will be an important determinant of whether this current bout of inflation is 'transitory'. If wages rise, this is likely to feed the inflationary beast. That said, we do not necessarily see a return to the bogeyman of 1970s levels of inflation when unionised labour had a far stronger voice. For now, we believe it is crucial to remain open-minded, cognisant that markets are not currently discounting structurally higher rates of inflation.

For the past two decades, with a few brief exceptions, we have lived in an era of benign inflation. Central banks, if anything, have been fighting deflationary shocks since the Asian and Long-Term Capital Management crises of the late 1990s and, more recently, the Great Financial Crisis of 2008, followed by the Eurozone debt crisis of 2011. Investors may be ill-prepared for rising interest rates; fixed income investors offered low nominal and negative real returns are being driven to higher-return equities, which supposedly offer 'real' protection.

 

The discount rate, the basis of which is determined by the 10-year US Treasury yield, is key. Equities have been supported by four decades of falling interest rates. Should this dynamic change, investors may be in for greater volatility as the support from low rates is questioned. This raises uncertainty over the value of the expected growth in earnings from equities, which becomes less precious when eroded by inflation. A battle lies ahead between the 'inflation-protecting' qualities of stocks and the threat of nominal interest rate rises in the future. There is a risk that some 'alternative assets' such as highly geared real estate similarly may not offer much defence.

We consider these risks when structuring the Trust's portfolio. Gold bullion and inflation-protected securities provide a foil for our equity exposure, which in turn is focussed on durable, profitable companies that continue to grow and have pricing power. Looking ahead, the Trust's liquidity will provide both downside protection and the ability to add to our equities as opportunities present themselves, as we did in the first quarter of 2020.

 

Sebastian Lyon, Investment Manager

 

Portfolio as at 31 October 2021

 

S/holders' Funds

Valuation

Bought/(sold) in period

Gain/(loss) in period

31 October 2021

Security

Country

Equity Sector

%

£'000

£'000

£'000

Equities

Microsoft

USA

Technology

6.2

105,437

198

26,011

Alphabet

USA

Technology

6.0

101,183

6,744

20,288

Nestlé

Switzerland

Food Producer

3.6

61,223

-

6,386

Unilever

UK

Food Producer

3.6

61,087

5,021

(4,565)

Visa

USA

Financial Services

3.4

57,415

6,699

(5,187)

Diageo

UK

Beverages

3.2

54,357

6,708

4,963

American Express

USA

Financial Services

2.9

49,706

-

6,237

Medtronic

USA

Healthcare

2.8

46,872

3,364

(3,727)

Franco Nevada

Canada

Mining

2.2

37,040

-

1,255

Agilent Technology

USA

Healthcare

2.0

33,776

(4,971)

6,558

Becton Dickinson

USA

Pharmaceuticals

1.6

27,378

3,348

(746)

Procter & Gamble

USA

Household Products

1.3

21,555

-

1,620

Experian

UK

Industrial

0.8

12,886

-

2,138

Moody's

USA

Financial Services

0.6

10,333

-

2,059

Pernod-Ricard

France

Beverages

0.5

8,391

-

964

Berkshire Hathaway

USA

Insurance

-

-

(34,563)

534

Philip Morris

USA

Tobacco

-

-

(60,010)

4,726

Total Equities

40.7

688,639

(67,462)

69,514

US TIPS

USA

30.3

513,027

13,337

9,144

UK T-Bills

UK

17.2

290,210

167,864

(142)

Gold Bullion

7.9

134,345

-

1,309

Total Investments

96.1

1,626,221

113,739

79,825

Property

0.1

2,144

-

-

UK cash

3.8

63,914

n/a

n/a

Overseas cash

0.0

9

n/a

n/a

Net current liabilities

(0.0)

(595)

n/a

n/a

TOTAL PORTFOLIO

100.0

1,691,693

n/a

n/a

 

 

 

Geographic Analysis of Investments and Currency Exposure As At 31 October 2021

 

UK

USA

Canada

France

Switzerland

Total

%

%

%

%

%

%

Equities

7.6

26.8

2.2

0.5

3.6

40.7

Index-Linked Securities

-

30.4

-

-

-

30.4

T-Bills

17.1

-

-

-

-

17.1

Gold Bullion

-

7.9

-

-

-

7.9

Property

0.1

-

-

-

-

0.1

Cash

3.8

0.0

-

-

-

3.8

Net current liabilities

(0.0)

-

-

-

-

(0.0)

Total

28.6

65.1

2.2

0.5

3.6

100.0

Net currency exposure

54.2

39.5

2.2

0.5

3.6

100.0

 

 

 

 

 

Statement of Principal Risks and Uncertainties

 

The Board believes that the principal risks to shareholders, which it seeks to mitigate through continual review of its investments and through shareholder communication, are events or developments which can affect the general level of share prices and other financial assets, including, for instance, inflation or deflation, economic recessions and movements in interest rates and currencies. There remain uncertainties resulting from the COVID-19 pandemic that may impact the Company, including investment risks surrounding the companies within the portfolio. The Board continues to work with the Investment Manager, Juniper Partners and its other advisers to manage these risks as far as possible in these uncertain times.

Other risks faced, and the way in which they are managed, are described in more detail under the heading Principal Risks and Risk Management within the Strategic Report in the Company's Annual Report for the year ended 30 April 2021.

 

The Company's principal risks and uncertainties have not changed since the date of the Annual Report and are not expected to change for the remaining six months of the Company's financial year.

 

Going Concern

 

The Directors acknowledge that the situation surrounding the COVID-19 pandemic continues to create risks and uncertainties which may impact the Company. Nevertheless, the Directors believe, in the light of the controls and review processes noted above and bearing in mind the nature of the Company's business and assets, which are considered readily realisable if required, that the Company has adequate resources to continue operating for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

 

Related Party Transactions

Details of related party transactions are contained in the Annual Report for the year ended 30 April 2021. There have been no material changes in the nature and type of the related party transactions as stated within the Annual Report.

 

 

Directors' Responsibility Statement in Respect of the Interim Report

We confirm that to the best of our knowledge:

· the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

· the Investment Manager's Report include a fair review of the information required by the Disclosure Guidance and Transparency Rules ("DTR") 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;

· the Statement of Principal Risks and Uncertainties is a fair review of the information required by DTR 4.2.7R; and

· the condensed financial statements include a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

On behalf of the Board,

Iain Ferguson, Chairman

23 November 2021

 

 

 

 

For further information, contact:

 

Sebastian Lyon

Investment Manager

Tel: 0207 499 4030

 

Carron Dobson

Juniper Partners Limited, Company Secretary

Tel: 0131 378 0500

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Income Statement

For the six months ended 31 October 2021

 

(Unaudited)

Six months ended

31 October 2021

Revenue

Capital

Return

Return

Total

£'000

£'000

£'000

Investment income

19,866

-

19,866

Other operating income

1

-

1

Gains on investments held at fair value through profit or loss

-

79,825

79,825

Foreign exchange losses

-

(3,841)

(3,841)

 

 

 

Total income

19,867

75,984

95,851

Expenses

(2,445)

(2,990)

(5,435)

 

 

 

Return before taxation

17,422

72,994

90,416

Taxation

(2,873)

2,474

(399)

 

 

 

Return for the period

14,549

75,468

90,017

 

 

 

Return per share

 

£4.34

 

£22.53

£26.87

 

The ''Return for the Period'' is also the ''Total Comprehensive Income for the period'', as defined in IAS1 (revised), and no separate Statement of Comprehensive Income has been presented.

The ''Total'' column of this statement represents the Company's Income Statement, prepared in accordance with International Financial Reporting Standards (''IFRSs'').

The Revenue Return and Capital Return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.

All items in the above statement derive from continuing operations.

 

 

 

 

 

 

 

 

 

 

 

Condensed Income Statement

For the six months ended 31 October 2020

 

(Unaudited)

Six months ended

31 October 2020

Revenue

Capital

Return

Return

Total

£'000

£'000

£'000

Investment income

8,263

-

8,263

Gains on investments held at fair value through profit or loss

-

22,944

22,944

Gain from discontinued operation

-

1,559

1,559

Foreign exchange gains

-

11,434

11,434

 

 

 

Total income

8,263

35,937

44,200

Expenses

(2,390)

(2,517)

(4,907)

 

 

 

Return before taxation

5,873

33,420

39,293

Taxation

(79)

-

(79)

 

 

 

Return for the period

5,794

33,420

39,214

 

 

 

Return per share

 

£2.03

£11.69

£13.72

 

Condensed Income Statement

For the year ended 30 April 2021

 

(Audited)

 

Year ended

 

30 April 2021

 

Revenue

Capital

 

Return

Return

Total

 

£'000

£'000

£'000

 

 

Investment income

19,005

-

19,005

 

Gains on investments held at fair value through profit or loss

-

80,865

80,865

 

Gain from discontinued operation

-

1,559

1,559

 

Foreign exchange gains

-

38,951

38,951

 

 

 

 

 

Total income

19,005

121,375

140,380

 

Expenses

(4,423)

(5,269)

(9,692)

 

 

 

 

 

Return before taxation

14,582

116,106

130,688

 

Taxation

(1,045)

482

(563)

 

 

 

 

 

Return for the period

13,537

116,588

130,125

 

 

 

 

 

Return per share

£4.53

£39.04

£43.57

 

Condensed Statement of Financial Position

As at 31 October 2021

 

(Unaudited)

(Unaudited)

(Audited)

31 October

31 October

30 April

2021

2020

2021

£'000

£'000

£'000

Non-current assets

 

Investments held at fair value through profit or loss

 

 

1,626,221

 

1,237,716

 

1,432,656

Property

2,144

2,105

2,144

Net current assets

63,328

73,941

69,136

 

 

 

Net assets

1,691,693

1,313,762

1,503,936

 

 

 

Total equity

1,691,693

1,313,762

1,503,936

 

 

 

Net asset value per Ordinary share

£489.77

£438.67

£465.19

 

 

 

 

 

Condensed Statement of Changes in Equity

For the six months ended 31 October 2021

(Unaudited)

(Unaudited)

(Audited)

Six months

Six months

Year

ended

ended

ended

31 October

31 October

30 April

2021

2020

2021

£'000

£'000

£'000

Opening equity shareholders' funds

1,503,936

1,160,966

1,160,966

Return for the period

90,017

39,214

130,125

Ordinary dividends paid

(9,331)

(7,963)

(16,644)

Issue of Ordinary shares

107,071

121,545

229,489

 

 

 

Closing equity shareholders' funds

1,691,693

1,313,762

1,503,936

 

 

 

 

 

Condensed Cash Flow Statement

For the six months ended 31 October 2021

 

(Unaudited)

(Unaudited)

(Audited)

Six months

Six months

Year

ended

ended

ended

31 October

31 October

30 April

2021

2020

2021

£'000

£'000

£'000

Net cash inflow from operating activities

 

1,006

2,605

6,487

Net cash outflow from investing

activities

(102,786)

(92,380)

(204,921)

 

 

 

Net cash outflow before financing

activities

(101,780)

(89,775)

(198,434)

Net cash inflow from financing

 

activities

94,818

113,031

213,932

 

 

 

Net (decrease)/increase in cash and

cash equivalents

(6,962)

23,256

15,498

Cash and cash equivalents at the start of

the period

70,907

56,091

56,091

Effect of exchange rate changes

(22)

(155)

(682)

 

 

 

Cash and cash equivalents at the end of

the period

63,923

79,192

70,907

 

 

 

 

 

NOTES

1. The condensed consolidated financial statements have been prepared in accordance with International Financial Reporting Standard ('IFRS') IAS 34 'Interim Financial Reporting' and the accounting policies set out in the statutory accounts of the Company for the year ended 30 April 2021. The condensed consolidated financial statements do not include all of the information required for a complete set of IFRS financial statements and should be read in conjunction with the consolidated financial statements of the Company for the year ended 30 April 2021, which were prepared under full IFRS requirements.

2. The return per Ordinary share figure is based on the net profit for the six months of £90,017,000 (six months ended 31 October 2020: net profit of £39,214,000; year ended 30 April 2021: net profit of £130,125,000) and on 3,349,647 (six months ended 31 October 2020: 2,858,320; year ended 30 April 2021: 2,986,288) Ordinary shares, being the weighted average number of Ordinary shares in issue during the respective periods.

3. In respect of the year ending 30 April 2022 the Board has declared a first interim dividend of £1.40 per Ordinary share, which was paid on 16 July 2021 and a second interim dividend of £1.40 per Ordinary share, which was paid on 8 October 2021. A third interim dividend of £1.40 per Ordinary share will be paid to shareholders on 12 January 2022 and a fourth interim dividend of £1.40 per Ordinary share is expected to be paid in April 2022, making a total for the year of £5.60 per Ordinary share. In respect of the year ended 30 April 2021 the Board declared four interim dividends of £1.40 per Ordinary share. This gave a total dividend for the year ended 30 April 2021 of £5.60 per Ordinary share.

 

4. At 31 October 2021 there were 3,454,079 Ordinary shares in issue (31 October 2020: 2,994,899; 30 April 2021: 3,232,929). During the six months ended 31 October 2021 the Company issued 221,150 new Ordinary shares.

 

5. The Board has considered the requirements of IFRS 8 'Operating Segments'. The Board is of the view that the Company is engaged in a single segment of business, being that of investing in equity shares, fixed interest securities and other investments, and that therefore the Company has only a single operating segment.

 

6. The Company held the following categories of financial instruments as at 31 October 2021:

 

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Investments

1,626,221

-

-

1,626,221

Current liabilities

-

(2,087)

-

(2,087)

Total

1,626,221

(2,087)

-

1,624,134

The above table provides an analysis of investments based on the fair value hierarchy described below and which reflects the reliability and significance of the information used to measure their fair value. The levels are determined by the lowest (that is, the least reliable or least independently observable) level of impact that is significant to the fair value measurement for the individual investment in its entirety as follows:

Level 1 reflects financial instruments quoted in an active market.

Level 2 reflects financial instruments the fair value of which is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique the variables of which include only data from observable markets. The Company's forward currency contract has been included in this level as fair value is achieved using the foreign exchange spot rate and forward points which vary depending on the duration of the contract.

Level 3 reflects financial instruments the fair value of which is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

There were no transfers of investments between levels in the period ended 31 October 2021.

 

The following table summarises the Company's Level 1 investments that were accounted for at fair value in the period to 31 October 2021.

 

 

£'000

Opening book cost

1,146,033

Opening fair value adjustment

286,623

Opening valuation

1,432,656

Movement in the period:

Purchases at cost

385,573

Effective yield adjustment

13,363

Sales - proceeds

(285,196)

- gains on sales

45,953

Increase in fair value adjustment

33,872

Closing valuation at 31 October 2021

1,626,221

Closing book cost

1,305,726

Closing fair value adjustment

320,495

Closing valuation at 31 October 2021

1,626,221

 

Other aspects of the Company's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 30 April 2021.

The fair value of the Company's financial assets and liabilities as at 31 October 2021 was not materially different from their carrying values in the financial statements.

 

7. These are not full statutory accounts in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory accounts for the year ended 30 April 2021, which received an unqualified audit report and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. No full statutory accounts in respect of any period after 30 April 2021 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

 

8. A copy of the Interim Report is available on the Company's website at www.patplc.co.uk. Shareholders are encouraged to visit the website for further information on the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BLBDBRSDDGBX
Date   Source Headline
26th Apr 20244:49 pmRNSTransaction in Own Shares
26th Apr 202411:36 amRNSNet Asset Value(s)
25th Apr 202412:43 pmRNSNet Asset Value(s)
24th Apr 20245:00 pmRNSTransaction in Own Shares
24th Apr 202411:43 amRNSNet Asset Value(s)
23rd Apr 20245:04 pmRNSTransaction in Own Shares
23rd Apr 202411:23 amRNSNet Asset Value(s)
22nd Apr 20245:38 pmRNSTransaction in Own Shares
22nd Apr 202412:09 pmRNSNet Asset Value(s)
19th Apr 20245:11 pmRNSTransaction in Own Shares
19th Apr 202412:02 pmRNSNet Asset Value(s)
18th Apr 20244:57 pmRNSTransaction in Own Shares
18th Apr 20243:25 pmRNSDirector/PDMR Shareholding
18th Apr 20243:24 pmRNSDirector/PDMR Shareholding
18th Apr 20243:23 pmRNSDirector/PDMR Shareholding
18th Apr 20243:23 pmRNSDirector/PDMR Shareholding
18th Apr 202411:55 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSTransaction in Own Shares
17th Apr 202410:40 amRNSNet Asset Value(s)
16th Apr 202410:55 amRNSNet Asset Value(s)
15th Apr 202412:51 pmRNSNet Asset Value(s)
12th Apr 20244:28 pmRNSTransaction in Own Shares
12th Apr 202411:47 amRNSNet Asset Value(s)
11th Apr 202410:56 amRNSNet Asset Value(s)
10th Apr 20244:19 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSDirectorate Change
10th Apr 202410:40 amRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 20241:07 pmRNSNet Asset Value(s)
8th Apr 20244:33 pmRNSTransaction in Own Shares
8th Apr 202411:24 amRNSNet Asset Value(s)
5th Apr 202411:58 amRNSNet Asset Value(s)
4th Apr 20244:38 pmRNSTransaction in Own Shares
4th Apr 202411:58 amRNSNet Asset Value(s)
3rd Apr 20244:36 pmRNSTransaction in Own Shares
3rd Apr 202412:07 pmRNSNet Asset Value(s)
2nd Apr 20244:52 pmRNSTransaction in Own Shares
2nd Apr 202412:23 pmRNSNet Asset Value(s)
2nd Apr 20249:39 amRNSTotal Voting Rights
28th Mar 20244:41 pmRNSTransaction in Own Shares
28th Mar 202410:57 amRNSNet Asset Value(s)
27th Mar 20244:45 pmRNSTransaction in Own Shares
27th Mar 20249:57 amRNSNet Asset Value(s)
26th Mar 20244:42 pmRNSTransaction in Own Shares
26th Mar 202412:05 pmRNSNet Asset Value(s)
25th Mar 20245:17 pmRNSTransaction in Own Shares
25th Mar 202411:40 amRNSNet Asset Value(s)
22nd Mar 20244:41 pmRNSTransaction in Own Shares
22nd Mar 202411:53 amRNSNet Asset Value(s)
21st Mar 20245:03 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.